Gene Expression publishes high-quality peer-reviewed research articles, reviews, and commentaries that advance understanding of the mechanisms, regulation, and functional consequences of gene expression in humans. The journal welcomes studies spanning molecular, cellular, developmental, and systems-level regulation of gene expression in both normal physiology and disease.

Gene Expression was launched in 1991 and published by Xia & He Publishing Inc. since 2022. The journal is indexed in Medline (1991-2021), Scopus, Biological Abstracts, Biosis Previews, ProQuest, and other databases.

Gene Expression (GE) adopts open access publishing model, and all articles are distributed under the terms of the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/). Under this license, anyone may copy, distribute, or reuse these articles for non-commercial purposes, provided the original work is properly cited. Manuscripts submitted for publication in an open access journal are subject to the same rigorous peer-review and quality control as in scholarly subscription journals.

GE recognizes the distinct advantages of using an open access publication model to timely disseminate innovative and important research findings. Unrestricted free access to our publications is anticipated to foster intellectual discourse across geographic and disciplinary boundaries. To support the success of our open access approach, we ensure the integrity and high quality of research published in our journal by practicing a rigorous peer review process and by following strict guidelines for ethics in publication and in conduct of the scientific process.

All manuscripts submitted to GE must meet the following criteria for publication:

• Topics with timely relevance to the general field or specialties in basic and clinical medicine;
• Results and findings that have not been previously published elsewhere;
• Research performed with adherence to accepted global standards for ethics in the scientific process;
• Ethical reporting of data to protect the rights and privacy of study participants;
• Appropriate statistical analyses, with sufficient descriptions of all statistical methods used;
• Conclusions supported by the data presented;
• All funding sources and their roles cited;
• For clinical trials, the registration number cited;
• Manuscript written in standard American (US) English and formatted according to the journal-specific guidelines;
• No instances of textual plagiarism, including ‘text recycling/self-plagiarism”.

GE currently publishes 4 issues a year.

GE follows an open access publishing model. Revenue is generated through article processing charges, permissions, and reprints. Currently, the publication costs are covered by the publisher.